Patents by Inventor Nancy Wedel

Nancy Wedel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of Crohn's disease or psoriasis using anti-interferon gamma antibodies
    Publication number: 20080260730
    Abstract: The present invention provides a method of treating autoimmune diseases. In particular, it provides a method for the treatment of Crohn's disease or psoriasis comprising administering to a subject in need thereof a therapeutically effective amount of an antibody against interferon ?.
    Type: Application
    Filed: May 24, 2007
    Publication date: October 23, 2008
    Applicant: PDL BioPharma, Inc.
    Inventors: Rolf Ehrhardt, Daniel J. Levitt, Beth Layug, Don O'Neill, Nancy Wedel, Lars Ostberg
  • Treatment of Crohn's disease or psoriasis using anti-interferon gamma antibodies
    Publication number: 20050019323
    Abstract: The present invention provides a method of treating autoimmune diseases. In particular, it provides a method for the treatment of Crohn's disease or psoriasis comprising administering to a subject in need thereof a therapeutically effective amount of an antibody against interferon ?.
    Type: Application
    Filed: March 19, 2004
    Publication date: January 27, 2005
    Applicant: Protein Design Labs, Inc.
    Inventors: Rolf Ehrhardt, Daniel Levitt, Beth Layug, Don O'Neill, Nancy Wedel, Lars Ostberg
  • Treatment of Crohn's disease or psoriasis using anti-interferon gamma antibodies
    Publication number: 20040052791
    Abstract: The present invention provides a method of treating autoimmune diseases. In particular, it provides a method for the treatment of Crohn's disease or psoriasis comprising administering to a subject in need thereof a therapeutically effective amount of an antibody against interferon &ggr;.
    Type: Application
    Filed: May 16, 2003
    Publication date: March 18, 2004
    Inventors: Rolf Ehrhardt, Dan Levitt, Beth Layug, Donald O'Neill, Nancy Wedel, Lars Ostberg
  • Human therapeutic uses of BPI protein products
    Patent number: 6586400
    Abstract: Disclosed are methods for treatment of humans exposed to bacterial endotoxin in circulation by administration of bactericidal/permeability-increasing (BPI) protein products. Serologically and hematologically verifiable alleviation of endotoxin mediated increases in circulating cytokines, fibrinolysis and coagulation factors and changes in lymphocyte counts are observed upon such treatment. Also observed is alleviation of endotoxin mediated decreases in systemic vascular resistance index (SVRI) and concomitant increases in cardiac index (CI).
    Type: Grant
    Filed: December 8, 2000
    Date of Patent: July 1, 2003
    Assignee: Xoma Corporation
    Inventors: Nadav Friedmann, Patrick J. Scannon, Sander J. H. van Deventer, Marijke A. M. von der Mohlen, Nancy Wedel
  • Human therapeutic uses of BPI Protein products
    Publication number: 20020094952
    Abstract: Disclosed are methods for treatment of humans exposed to bacterial endotoxin in circulation by administration of bactericidal/permeability-increasing (BPI) protein products. Serologically and hematologically verifiable alleviation of endotoxin mediated increases in circulating cytokines, fibrinolysis and coagulation factors and changes in lymphocyte counts are observed upon such treatment. Also observed is alleviation of endotoxin mediated decreases in systemic vascular resistance index (SVRI) and concomitant increases in cardiac index (CI).
    Type: Application
    Filed: December 8, 2000
    Publication date: July 18, 2002
    Applicant: XOMA Corporation
    Inventors: Nadav Friedmann, Patrick J. Scannon, Sander J.H. van Deventer, Marijke A.M. von der Mohlen, Nancy Wedel
  • Human therapeutic uses of BPI protein products
    Patent number: 6191112
    Abstract: Disclosed are methods for treatment of humans exposed to bacterial endotoxin in circulation by administration of bactericidal/permeability-increasing (BPI) protein products. Serologically and hematologically verifiable alleviation of endotoxin mediated increases in circulating cytokines, fibrinolysis and coagulation factors and changes in lymphocyte counts are observed upon such treatment. Also observed is alleviation of endotoxin mediated decreases in systemic vascular resistance index (SVRI) and concomitant increases in cardiac index (CI).
    Type: Grant
    Filed: September 2, 1999
    Date of Patent: February 20, 2001
    Assignee: Xoma Corporation
    Inventors: Nadav Friedmann, Patrick J. Scannon, Sander J. H. van Deventer, Marijke A. M. von der Mohlen, Nancy Wedel
  • Human therapeutic uses of BPI protein products
    Patent number: 5952302
    Abstract: Disclosed are methods for treatment of humans exposed to bacterial endotoxin in circulation by administration of bactericidal/permeability-increasing (BPI) protein products. Serologically and hematologically verifiable alleviation of endotoxin mediated increases in circulating cytokines, fibrinolysis and coagulation factors and changes in lymphocyte counts are observed upon such treatment. Also observed is alleviation of endotoxin mediated decreases in systemic vascular resistance index (SVRI) and concomitant increases in cardiac index (CI).
    Type: Grant
    Filed: May 18, 1998
    Date of Patent: September 14, 1999
    Assignee: Xoma Corporation
    Inventors: Nadav Friedmann, Patrick J. Scannon, Sander J.H. van Deventer, Marijke A.M. von der Mohlen, Nancy Wedel
  • Therapeutic uses of BPI protein products in humans with hemorrhage due to trauma
    Patent number: 5945399
    Abstract: Methods and materials for the treatment of humans suffering from hemorrhage due to trauma are provided, in which therapeutically effective amounts of BPI protein products are administered.
    Type: Grant
    Filed: May 23, 1997
    Date of Patent: August 31, 1999
    Assignee: XOMA Corporation
    Inventors: Patrick J. Scannon, Nancy Wedel
  • Therapeutic uses of BPI protein products in humans with hemmorhage due to trauma
    Patent number: 5756464
    Abstract: Methods and materials for the treatment of humans suffering from hemorrhage due to trauma are provided, in which therapeutically effective amounts of BPI protein products are administered.
    Type: Grant
    Filed: September 10, 1997
    Date of Patent: May 26, 1998
    Assignee: XOMA Corporation
    Inventors: Patrick J. Scannon, Nancy Wedel
  • Human therapeutic uses of BPI protein products
    Patent number: 5753620
    Abstract: Disclosed are methods for treatment of humans exposed to bacterial endotoxin in circulation by administration of bactericidal/permeability-increasing (BPI) protein products. Serologically and hematologically verifiable alleviation of endotoxin mediated increases in circulating cytokines, fibrinolysis and coagulation factors and changes in lymphocyte counts are observed upon such treatment. Also observed is alleviation of endotoxin mediated decreases in systemic vascular resistance index (SVRI) and concomitant increases in cardiac index (CI).
    Type: Grant
    Filed: January 24, 1995
    Date of Patent: May 19, 1998
    Assignee: XOMA Corporation
    Inventors: Nadav Friedmann, Patrick J. Scannon, Sander J. H. van Deventer, Marijke A. M. von der Mohlen, Nancy Wedel
  • Human therapeutic uses of bactericidal/permeability increasing (BPI) protein products
    Patent number: 5643875
    Abstract: Disclosed are methods for treatment of humans exposed to bacterial endotoxin in circulation by administration of bactericidal/permeability-increasing (BPI) protein products. Serologically and hematologically verifiable alleviation of endotoxin mediated increases in circulating cytokines, fibrinolysis and coagulation factors and changes in lymphocyte counts are observed upon such treatment. Also observed is alleviation of endotoxin mediated decreases in systemic vascular resistance index (SVRI) and concomitant increases in cardiac index (CI).
    Type: Grant
    Filed: August 16, 1994
    Date of Patent: July 1, 1997
    Inventors: Nadav Friedmann, Patrick J. Scannon, Sander J. H. van Deventer, Marijke A. M. von der Mohlen, Nancy Wedel